学术活动
  • 2015/09/07 Dynamics of the Human Microbiome
  • 2014/10/23 Evolution of Natural Products for Cancer Chemotherapy
  • 2014/09/23 Transcriptional Engineering Tools for E. coli
  • 2014/07/14 Genome Evolution of a Versatile Lineage – From Cultures to Single Cell Genomics
  • 2014/05/19 Probing the diversified bacterial lipid metabolism, an attractive anti-bacterial drug target
  • 2014/03/19 Starting S Phase: activation of the helicase
  • 2014/02/18 Glycosylation of Small Molecule Using Flexible Glycosyltransferase
  • 2013/12/03 Novel Regulation and Function of the Tumor Suppressor PTEN
  • 2013/10/25 Natural Product Chemistry Research - How Environmental Science studies have translated into Biodiscovery
  • 2013/06/28 Biotechnology Paradigm Shift: From Living Microorganisms to Cell-Free Biosystems
  • 2013/05/20 Correlation of genetic and cardiovascular risk markers with blood telomere length–understanding role of telomere in cardiovascular disease
  • 2013/03/18 Exploring Cancer pathways using model organisms: from Hedgehog to Hippo.
  • 2012/12/17 The Evolution of Microbial Ecology
  • 2012/12/04 How much of the human genome is functional?
  • 2012/11/05 Non-classical roles of vitamin D and vitamin D receptor in inflammation and cancer: beyond bone
  • 2012/09/14 Regulation of Innate Immunity and Inflammation by Notch Signaling
  • 2012/07/03 Drosophila as a model for human disease: Insights into neurodegeneration and acute neural injury
  • 2011/05/26 UNDERSTANDING HOW GENOMES REGULATE COMPLEX BIOLOGICAL PROCESSES
  • 2010/9/10 Mechanobiological Insights into the Patho-physiology of Human Diseases
  • 2010/8/12 Aids in 2011: new pathophysiological concept- Prospect for a cure
  • 2010/6/25 Kinetic Models of Gene Regulatory Networks
  • 2010/6/8 How to get published in Science
  • 210/6/4 A p53-based strategy for cancer therapy protection
  • 2010/3/1 负氢离子的特性、基础研究以及临床效果
  • 2010/1/20 Engineering hydrolases to catalyze new reactions
  • 2013/06/28 Biotechnology Paradigm Shift: From Living Microorganisms to Cell-Free Biosystems首页>学术活动>

    报告题目:Biotechnology Paradigm Shift: From Living Microorganisms to Cell-Free Biosystems
    报 告 人:Y.-H. Percival Zhang , Ph.D.
                   Biological Systems Engineering Department,Virginia Tech,304 Seitz Hall,Blacksburg,Virginia 24061,USA
    报告时间:2013-06-28(周五)上午10:00
    报告地点:生物药学楼3号楼105
    Abstract:Cell-free biosystems for manufacturing (CFBM) are the implementation of complicated biological reactions via the in vitro assembly of numerous (stable) enzymes originated from different sources and/or (biomimetic) cofactors 1-5. CFBM features numerous industrial production advantages: high product yield, fast reaction rate, easy access and control for open systems, tolerance of toxic compounds, broad reaction conditions, and so on. In this talk, I will present numerous CFBM examples, for example, the theoretical yield hydrogen production from sugars (e.g., pentoses and hexoses) 6-8, enzymatic conversion of cellulose to starch (amylose) 9, and (iii) super-energy density sugar-powered biobatteries. CFBM would become a high-yield and low-cost manufacturing platform and lead to a biotechnology paradigm shift, especially in the sustainability revolution pertaining to the energy-water-food nexus 10,11.


    Copyright © 2024 上海交大生命科学与健康创新实验室 All Rights Reserved | 技术支持:彭塔互联